Snapshot from Jun 09, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Immutep securities fraud class action
Business class action lawsuit

Immutep securities fraud class action

Analysis based on 36 articles · First reported May 07, 2026 · Last updated May 27, 2026

Sentiment
-70
Attention
4
Articles
36
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Immutep could lead to a significant decline in its stock price due to potential legal liabilities and damage to its reputation. Investors who purchased Immutep ADRs during the Class Period may be entitled to compensation, impacting their investment returns.

biotechnology legal services
Event Summary

Rosen Law Firm has announced and is actively encouraging investors to join a class action lawsuit against Immutep Ltd. The lawsuit alleges that Immutep made false and misleading statements and concealed information regarding the status and prospects of its TACTI004 trial between March 24, 2025, and March 12, 2026. Specifically, Immutep allegedly misrepresented the trial's progress and the interim futility analysis, despite internal data suggesting a high risk of failure. Investors who purchased Immutep ADRs during this period are encouraged to secure counsel before the lead plaintiff deadline of July 6, 2026. Attorneys Philip Kim and Lawrence Rosen are key contacts for this litigation.

Key Actions
98 Rosen Law Firm investigates claims Immutep
89 Immutep issued press release
85 Rosen Law Firm reminded purchasers
70 Immutep filed Form-K United States — United States Securities and Exchange Commission
Entities Involved
stock
Immutep
Immutep is the defendant in a class action lawsuit alleging false and misleading statements regarding its TACTI004 trial, which could lead to significant financial damages and reputational harm.
Importance 100 Sentiment -80
priv
Rosen Law Firm
Rosen Law Firm is initiating and encouraging investors to join a class action lawsuit against Immutep, aiming to secure compensation for affected shareholders.
Importance 90 Sentiment 50
per
Philip Kim
Philip Kim, an attorney at Rosen Law Firm, is a key contact for investors interested in joining the class action lawsuit against Immutep.
Importance 70 Sentiment 40
per
Lawrence Rosen
Lawrence Rosen, founding partner of Rosen Law Firm, is highlighted for his firm's success in securities class actions, lending credibility to the lawsuit against Immutep.
Importance 70 Sentiment 40
govactor
United States — United States Securities and Exchange Commission
Immutep filed a Form-K with the United States — United States Securities and Exchange Commission, which is referenced in the lawsuit as containing allegedly misleading statements.
Importance 30 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.